Skip to content
Stock screener

SYK Stryker Corp stock chart & analysis

Conviction 28HealthcareScan · Fri, Nov 6, 2026

Stryker Corp (SYK) closed at $325.87 (-2.75%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 61, RS Rating 35, -16.3% from its 52-week high, -7.3% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.

SYK$325.87-2.75%
ResistanceSupportVol 14Insider buyInsider sellCongress buyCongress sell
Loading chart…
Stryker CorpSurgical & Medical Instruments & Apparatuswww.stryker.com ↗
Price325.87
Change-2.75%
Gap-2.80%
Rel volume1.63×
Avg volume3.21M
Avg $ vol988.53M
SMA 20304.10
SMA 50292.27
SMA 200322.87
Price vs 50+11.48%
Price vs 200+0.91%
MA stackmixed
50/200 cross—
Supertrendup · 299.87
RSI (14)61
MACD hist3.41
MACD cross—
Stoch %K / %D65 / 80
ADX (14)19
+DI / −DI37 / 22
RSI divergence—
MACD divergence—
ATR %3.71%
ADR %3.15%
52w high389.33
52w low267.00
From 52w high-16.31%
Above 52w low+22.03%
New 52w highNo
SqueezeOff
Bollinger width20.17%
%B0.85
Donchian pos68.44%
Donchian high349.48
Donchian low274.50
AVWAP (52w high)313.81
vs AVWAP high+3.83%
AVWAP (52w low)292.60
vs AVWAP low+11.35%
OBV trendUp
Chaikin MF (20)0.28
Today vs 20d1.63×
Avg vol (14d)3.47M
Avg vol (20d)3.21M
Avg $ vol (20d)988.53M
Market cap124.04B
RS Rating35 / 99
RS 3m (vs SPY)-0.91%
RS 6m (vs SPY)+14.44%
RS line new highNo
Trend template3/8
Technical rank84.9
1 week+11.64%
1 month+17.64%
3 months-5.78%
6 months+14.13%
1 year-8.90%
YTD-7.30%
P/E38.21
P/B5.29
P/S4.94
P/FCF28.96
EPS8.40
Div yield1.04%
ROE13.84%
ROA6.87%
Debt/Eq0.64
Current2.18
EV/EBITDA21.01
Gross margin63.96%
Net margin12.92%
Rev growth11.16%
EPS growth8.45%
Price target337.53
Target upside3.59%
Analyst ratingBuy
Institutional91.43%
Ent. value135.7B
Revenue6.52B
Net income753M
Gross profit4.25B
Free cash flow4.28B
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNYSE
Shares out383.36M
Employees56K
ListedWed, May 2, 1979
Free float345.45M
Float %90.3%
Short interest—
Days to cover—
Short volume61.8%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$3.52 vs $3.56
Last surprise-1.1% miss
Setup gradeD
Conviction28 / 100
Pattern quality—
Tech rank84.9 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance311.24
Support270.52
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

SYK technical analysis

Trend

SYK's moving averages are mixed — no clean uptrend or downtrend. It closed 11.5% above the 50-day ($292.27) and 0.9% above the 200-day ($322.87). ADX(14) at 19 points to a weak trend — more range than direction. It meets 3 of 8 trend-template criteria.

Momentum

RSI(14) is 61, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 35 puts its weighted 12-month performance ahead of about 35% of the US market.

Volume and volatility

Volume on the latest session ran 1.6× its 20-day average. It trades about $988.5M a day on average. ATR(14) is $12.08, 3.7% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.28) shows accumulation.

Key levels

The chart pattern's support is $270.52 and its resistance $311.24. The 52-week range is $267.00 to $389.33; price is 16.3% below the high and 22.0% above the low. The VWAP anchored at the 52-week high is $313.81, below price.

Performance

SYK returned +11.6% (1 week), +17.6% (1 month), -5.8% (3 months), +14.1% (6 months), -8.9% (1 year), -7.3% (year to date).

About Stryker Corp

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Surgical & Medical Instruments & Apparatus · Listed 1979 · 56,000 employees

Congress activity

Disclosed STOCK Act trades in SYK · 10 recent

All disclosures →
MemberSideAmount
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2026-09-30
Sell$1K–$15K
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2026-07-22
Sell$1K–$15K
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Sell$15K–$50K
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2026-06-02
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2025-12-10
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2025-11-18
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2025-10-17
Buy$1K–$15K
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2025-09-12
Sell$15K–$50K
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2025-08-25
Sell$1K–$15K
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2025-07-31
Sell$15K–$50K

Insider activity

SEC Form 4 transactions in SYK · open-market 5 buys · 5 sells

InsiderSideShares
BRAINERD MARY K
Director · Common Stock · 2022-11-22
Buy18
BRAINERD MARY K
Director · Common Stock · 2020-06-12
Buy3
BRAINERD MARY K
Director · Common Stock · 2020-05-12
Buy36
BRAINERD MARY K
Director · Common Stock · 2019-09-12
Buy11
BRAINERD MARY K
Director · Common Stock · 2019-06-26
Buy63
Crotty Dylan Bram
Group President · Common Stock · 2026-08-21
Sell441
STRYKER RONDA E
Director · Common Stock · 2026-08-19
Sell80
STRYKER RONDA E
Director · Common Stock · 2026-08-19
Sell805
STRYKER RONDA E
Director · Common Stock · 2026-08-19
Sell40
STRYKER RONDA E
Director · Common Stock · 2026-08-19
Sell440

SEC filings

EDGAR filings in SYK · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.